"The U.S. Food and Drug Administration today approved a new use for Jakafi (ruxolitinib) to treat patients with polycythemia vera, a chronic type of bone marrow disease. Jakafi is the first drug approved by the FDA for this condition.
Agrylin Patient Information including How Should I Take
In this Article
- What is anagrelide (Agrylin)?
- What are the possible side effects of anagrelide (Agrylin)?
- What is the most important information I should know about anagrelide (Agrylin)?
- What should I discuss with my healthcare provider before taking anagrelide (Agrylin)?
- How should I take anagrelide (Agrylin)?
- What happens if I miss a dose (Agrylin)?
- What happens if I overdose (Agrylin)?
- What should I avoid while taking anagrelide (Agrylin)?
- What other drugs will affect anagrelide (Agrylin)?
- Where can I get more information?
What should I discuss with my healthcare provider before taking anagrelide (Agrylin)?
You should not use anagrelide if you are allergic to it, or if you have moderate to severe liver disease.
To make sure you can safely take anagrelide, tell your doctor if you have any of these other conditions:
- liver disease;
- heart disease or congestive heart failure;
- kidney disease; or
- asthma, chronic obstructive pulmonary disease (COPD), or other breathing disorder.
FDA pregnancy category C. It is not known whether anagrelide will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.
It is not known whether anagrelide passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are using anagrelide.
How should I take anagrelide (Agrylin)?
Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.
Your doctor may occasionally change your dose to make sure you get the best results.
To be sure this medication is helping your condition and not causing harmful effects, your blood will need to be tested often. Your kidney and liver function may also need to be tested. Visit your doctor regularly.
Do not stop taking anagrelide without first talking to your doctor. Stopping suddenly can make your condition worse very quickly.
If you need surgery, tell the surgeon ahead of time that you are using anagrelide. Tell any doctor or dentist who treats you that you are taking anagrelide.
Store at room temperature away from moisture, heat, and light.
Additional Agrylin Information
- Agrylin Drug Interactions Center: anagrelide oral
- Agrylin Side Effects Center
- Agrylin Overview including Precautions
- Agrylin FDA Approved Prescribing Information including Dosage
Agrylin - User Reviews
Agrylin User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.